OPTIMIZING THE DRUG SUPPLY STRATEGY

Predictive Drug Supply Model

Discover how a Sponsor optimized the drug delivery via IDDI’s Proposition of a Predictive Drug Supply Model.

SITUATION:

  • Phase II 
  • Efficacy assessment of a new drug in combination with an antibody in patients with advanced triple negative breast cancer
  • Expensive drug to manufacture
  • Different compositions for both Placebo and Active drugs:
    • 5 mg vials
    • 3 mg vials
    • 2 mg vialsIn case of an event, drug dose reduction occurs
  • Difficult to predict 3 mg and 2 mg drug allocations
  • Usage of central pharmacies


SPONSOR’S REQUEST:
Optimize the drug delivery (limit the quantity of shipped vials yet assure sufficient vials are on site)

PLEASE FILL IN THE FORM TO ACCESS THE CASE STUDY  

OPTIMIZING THE DRUG SUPPLY STRATEGY

    By submitting this form, you agree to receiving commercial electronic messages such as e-mails from IDDI. For more info, please visit our Privacy Policy. You can unsubscribe at any time by clicking the 'unsubscribe' button at the foot of any e-mail communication from IDDI.

    I authorize IDDI to use my data to contact me for commercial purposes.More information